REBYOTA has confirmed >90% coverage for commercially and government-insured patients.* Learn More

*REBYOTA Connect Benefits Verifications for commercially AND government-insured patients through March 1, 2024.

interior banner large

ORDER REBYOTA®

The ordering process for REBYOTA
is streamlined to integrate efficiently into your operational workflow.

overlay section BG

3 WAYS TO ORDER REBYOTA

There are multiple ways to obtain REBYOTA for your patients. There may be payer-dependent requirements—running a benefits verification is the best way to confirm.

  • Specialty Distributors (SD)

    Order through an SD by setting up an account and following their application process.

  • REBYOTA @ Home

    Offer your patients in-home administration with REBYOTA with consideration to location constraints, physical limitations, or administrative obstacles.

  • Specialty Pharmacy (SP)

    Pending a patient benefits verification, you can order through an SP. You will work with the SP to handle all logistics.

What you need to know to set up your account and order REBYOTA

SPECIALTY DISTRIBUTOR ACCOUNT SET UP

This step is only needed if you don’t have an in-network Specialty Distributor account currently set up:

Prior to ordering REBYOTA for your patients, you will need to ensure you have an SD account within our network. We have provided a couple steps to get you started.

Identify which Specialty Distributor you would like to use within the network

The SD network account set up information chart below contains the specific contact information you will need to begin the process with your preferred SD.

  • Each SD has its own application process, turnaround time, and list of documentation that is needed to submit an order
  • Address verification may be required

SPECIALTY DISTRIBUTOR ACCOUNT SET UP INFORMATION

Besse

Tel: 1-800-543-2111
Email: accountsetup@besse.com
Online portal: www.besse.com/create-an-account

Cardinal Health™
Metro Medical™

Tel: 1-800-768-2002
Email: customersvc@cardinalhealth.com
Online ordering portal: www.metromedicalorder.com

  • Visit www.metromedical.com. On the first screen, click on “Request information
    or set up an account” in the red box
  • Fill out the form and someone will contact you
  • If you have any questions during account registration, customers can call
    customer service at: 800-768-2002

Cardinal Specialty

Tel: 1-866-677-4844
Online Portal*: www.cardinalhealth.com/en/solutions/specialty-distribution/ordering/creating-an-account.html
*Online portal is for hospitals and pharmacies only; physician offices must call to initiate an account.

CuraScript

Tel: 1-877-599-7748
Email: ssatservice@curascript.com

McKesson Specialty

McKesson Plasma and Biologics
Email: MPBOnboarding@mckesson.com


McKesson Specialty Health
Email: onboarding2@mckesson.com

Optum Frontier
Therapies

Tel: 1-833-754-6457
Email: oft_specialtydistribution@optum.com

McKesson Medical-
Surgical, Inc

Tel: 1-800-422-0280
Email: Contact Supply Manager through Help Desk for Tech support with the form: 800-422-0280
Hours of Operations to contact with questions: 8AM – 8PM EST
Website to complete application: www.besse.com/create-an-account
Click on BECOME A CUSTOMER link and complete form
Estimated time frame/duration for account set-up from submission of COMPLETE paperwork to being able to order. Varies based on size of practice and length of time it takes for sales team to connect with potential customer.

May take a minimum 72 hours for an account set up.

ORDER REBYOTA

Once you have set up your account with your preferred SD, you can order REBYOTA.

When ordering REBYOTA from a Specialty Distributor, please keep in mind:

  • Orders placed on Monday–Thursday before 3:00 PM ET will arrive by 10:30 AM local time the following day
  • Orders placed Friday by 3:00 PM ET will arrive Tuesday by 10:30 AM in the local time zone
  • Orders outside of this standard window are available upon request, including Saturday or Monday delivery
  • Ferring has worked with SDs on extended payment terms. Inquire with your SD

SPECIALTY DISTRIBUTOR ordering INFORMATION

Besse

Tel: 1-800-543-2111
Hours: Monday–Thursday, 8:00 AM–7:00 PM ET and Friday, 8:00 AM–5:00 PM ET

Cardinal Health™
Metro Medical™

Tel: 1-800-768-2002
Email: customersvc@cardinalhealth.com
Online Ordering Portal: www.metromedicalorder.com

Cardinal Specialty

Tel: 1-855-855-0708
Hours: Monday–Friday, 8:00 AM–7:00 PM ET

CuraScript

Tel: 1-877-599-7748
Fax: 1-888-227-8158
Email: ssatservice@curascript.com
Hours: Monday–Friday, 8:30 AM–5:30 PM ET

McKesson Specialty

McKesson Plasma and Biologics
Tel: 1-877-625-2566
Fax: 888-752-7626
Email: mpborders@mckesson.com
Online Ordering Portal: connect.mckesson.com
Hours: 8:00 AM–6:30 PM CT


McKesson Specialty Health
Tel: 1-855-477-9800
Fax: 800-800-5673
Email: mshcustomercare-mspl@mckesson.com
Online Ordering Portal: mscs.mckesson.com
Hours: 7:00 AM–7:00 PM CT

Optum Frontier
Therapies

Tel: 1-833-754-6457
Email: oft_specialtydistribution@optum.com

McKesson Medical-
Surgical, Inc

Tel: 1-855-571-2100
Email: MMSPCCustomerService@mckesson.com
Ordering Portal (if exists) for web-based ordering: https://mms.mckesson.com/
Hours of Operations to accept orders: 8:00 AM-8:00 PM EST Customer Service

WHEN ORDERING FROM AN SD, REBYOTA WILL ARRIVE IN AN ORANGE SHIPPER BOX

REBYOTA contains live microorganisms; it is important to follow proper storage requirements:

  • REBYOTA can stay in the unopened orange shipper box up to 5 days from date on box
  • Follow unpacking instructions printed on the orange shipper box for storage and thawing requirements
  • AEROSAFE will facilitate box returns with a phone call 1-2 days after receipt

– Tel: 1-585-328-2140

REBYOTA @ HOME

  • Offer your patients in-home administration with consideration to:
    • Location constraints
    • Physical limitations
    • Administrative obstacles
  • REBYOTA @ Home manages the process from start to finish
  • In-home health nurses, available in all 50 states, coordinate administration

Initiate REBYOTA @ Home by filling out our Patient Enrollment form to begin the benefits verification process.

Follow these enrollment steps:

  1. Complete a patient enrollment form
  2. Check the REBYOTA @ Home box on the form
  3. Fax completed form to 1-877-778-7167

For help in verifying a patient’s
insurance coverage, call
REBYOTA CONNECT at
1-877-REBYOTA (1-877-732-9682)

REBYOTA @ Home Administration

Watch this video to see how the in-home nurse will administer REBYOTA in the convenience of your patient’s home.

REBYOTA may be dispensed via specialty pharmacies

There may be payer-dependent requirements—running a benefits verification is the best way to confirm.

Please work with your SP on logistics, handling, and their specific returns and replacement policies.

SPECIALTY PHARMACY ORDERING INFORMATION

  • Optum Frontier Therapies: Tel: 1-855-768-9727. Hours: 24/7
  • Accredo: Prescription Tel: 1-866-759-1557. Customer Service Tel: 1-877-626-1511. Hours: 9:00 AM-11:00 PM ET
REBYOTA support and reimbursement icon

For any product questions or to inquire about a direct purchase option via credit card, please call 1-877-REBYOTA (1-877-732-9682)

For any product questions or to inquire about a direct purchase option,

REBYOTA support and reimbursement icon

please call 1-877-REBYOTA (1-877-732-9682)

REBYOTA PRODUCTION INFORMATION

NDC#

55566-9800-2

How supplied

REBYOTA and the administration set are shipped together in a box. Each box may contain up to 6 cartons of REBYOTA and up to 6 administration sets. Each carton of REBYOTA (NDC 55566-9800-2) contains a single dose.

Storage and
handling

REBYOTA contains live microorganisms. It is important to follow the storage requirements.
Upon Receipt: Store the REBYOTA carton in an ultracold freezer (-60°C to -90°C, -76°F to -130°F). Alternatively, store in a refrigerator (2°C to 8°C, 36°F to 46°F) for up to 5 days (including thaw time). Do not refreeze REBYOTA after thawing. Store the administration set at 10°C to 34°C (50°F to 93°F). DO NOT store the administration set in the freezer.
Before Using: Prior to use, thaw REBYOTA completely by placing carton in a refrigerator (2°C to 8°C, 36°F to 46°F) for approximately 24 hours. Do not refreeze REBYOTA after thawing. Dispose of all components in medical waste.

Carton size

Product box: 9 7/16” x 5 6/16” x 1”

Tube kit box: 9 7/16” x 5 6/16” x 1”

Combined: 18 14/16” x 5 12/16” x 2”

Carton weight

Product: 0.264 kg each
Admin Set: 0.09 kg each

REBYOTA support and reimbursement icon

REBYOTA Support and Reimbursement

Support for providers as well as patients.

Why REBYOTA icon

Why Rebyota

Answers to REBYOTA questions including administration, safety, patient expectations, and more.

Sign up to receive information
and updates on REBYOTA

Mailing Address

*Required field.

IMPORTANT SAFETY INFORMATION

INDICATION

REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment for recurrent CDI.
Limitation of Use
REBYOTA is not indicated for treatment of CDI.

IMPORTANT SAFETY INFORMATION

Contraindications
Do not administer REBYOTA to individuals with a history of a severe allergic reaction (eg, anaphylaxis) to any of the known product components.
Warnings and Precautions
Transmissible infectious agents

Because REBYOTA is manufactured from human fecal matter, it may carry a risk of transmitting infectious agents. Any infection suspected by a physician possibly to have been transmitted by this product should be reported by the physician or other healthcare provider to Ferring Pharmaceuticals Inc.
Management of acute allergic reactions
Appropriate medical treatment must be immediately available in the event an acute anaphylactic reaction occurs following administration of REBYOTA.
Potential presence of food allergens
REBYOTA is manufactured from human fecal material and may contain food allergens. The potential for REBYOTA to cause adverse reactions due to food allergens is unknown.
Adverse Reactions
The most commonly reported (≥3%) adverse reactions occurring in adults following a single dose of REBYOTA were abdominal pain (8.9%), diarrhea (7.2%), abdominal distention (3.9%), flatulence (3.3%), and nausea (3.3%).
Use in Specific Populations
Pediatric Use
Safety and efficacy of REBYOTA in patients below 18 years of age have not been established.
Geriatric Use
Of the 978 adults who received REBYOTA, 48.8% were 65 years of age and over (n=477), and 25.7% were 75 years of age and over (n=251). Data from clinical studies of REBYOTA are not sufficient to determine if adults 65 years of age and older respond differently than younger adults.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch, or call
1-800-332-1088.

Please click here for full Prescribing Information.

Are you a US healthcare professional?